IDO1 and autoimmune disease: Indoleamine 2,3-dioxygenase 1 (IDO1) was first recognized as an immune regulator in pregnancy (1), and subsequently, in numerous experimental and clinical settings, including autoimmune diseases, chronic inflammation, transplantation, and neoplasia (2).